WallStreetZenWallStreetZen

NASDAQ: AWH
Aspira Women's Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AWH

Based on 2 analysts offering 12 month price targets for Aspira Women's Health Inc.
Min Forecast
$3.30+287.78%
Avg Forecast
$4.40+417.04%
Max Forecast
$5.50+546.3%

Should I buy or sell AWH stock?

Based on 2 analysts offering ratings for Aspira Women's Health Inc.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AWH stock forecasts and price targets.

AWH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-14
lockedlocked$00.00+00.00%2024-04-10

1 of 1

Forecast return on equity

Is AWH forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is AWH forecast to generate an efficient return on assets?
Company
-352.81%
Industry
10.09%
AWH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AWH earnings per share forecast

What is AWH's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.26
Avg 2 year Forecast
-$0.87

AWH revenue forecast

What is AWH's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.1M+13.19%
Avg 2 year Forecast
$12.5M+40.09%
AWH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AWH revenue growth forecast

How is AWH forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
13.19%
Industry
4.68%
Market
10.22%
AWH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AWH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AWH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
AWH$0.85$4.40+417.04%Buy
PMD$2.33N/AN/A
STRR$4.12N/AN/A
APDN$1.37$1.50+9.49%Buy
TRIB$1.60N/AN/A
View Top Diagnostic & Research Stocks

Aspira Women's Health Stock Forecast FAQ

Is Aspira Women's Health Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: AWH) stock is to Buy AWH stock.

Out of 2 analysts, 1 (50%) are recommending AWH as a Strong Buy, 0 (0%) are recommending AWH as a Buy, 1 (50%) are recommending AWH as a Hold, 0 (0%) are recommending AWH as a Sell, and 0 (0%) are recommending AWH as a Strong Sell.

If you're new to stock investing, here's how to buy Aspira Women's Health stock.

What is AWH's earnings growth forecast for 2024-2025?

(NASDAQ: AWH) Aspira Women's Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 45.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.4%.

Aspira Women's Health's earnings in 2024 is -$15,954,000.On average, 2 Wall Street analysts forecast AWH's earnings for 2024 to be -$20,239,303, with the lowest AWH earnings forecast at -$21,363,709, and the highest AWH earnings forecast at -$19,114,897.

In 2025, AWH is forecast to generate -$13,974,757 in earnings, with the lowest earnings forecast at -$13,974,757 and the highest earnings forecast at -$13,974,757.

What is AWH's revenue growth forecast for 2024-2025?

(NASDAQ: AWH) Aspira Women's Health's forecast annual revenue growth rate of 13.19% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.68%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.22%.

Aspira Women's Health's revenue in 2024 is $8,923,000.On average, 1 Wall Street analysts forecast AWH's revenue for 2024 to be $162,235,684, with the lowest AWH revenue forecast at $162,235,684, and the highest AWH revenue forecast at $162,235,684.

In 2025, AWH is forecast to generate $200,786,738 in revenue, with the lowest revenue forecast at $200,786,738 and the highest revenue forecast at $200,786,738.

What is AWH's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: AWH) forecast ROA is -352.81%, which is lower than the forecast US Diagnostics & Research industry average of 10.09%.

What is AWH's Price Target?

According to 2 Wall Street analysts that have issued a 1 year AWH price target, the average AWH price target is $4.40, with the highest AWH stock price forecast at $5.50 and the lowest AWH stock price forecast at $3.30.

On average, Wall Street analysts predict that Aspira Women's Health's share price could reach $4.40 by Aug 14, 2025. The average Aspira Women's Health stock price prediction forecasts a potential upside of 417.04% from the current AWH share price of $0.85.

What is AWH's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: AWH) Aspira Women's Health's current Earnings Per Share (EPS) is -$1.42. On average, analysts forecast that AWH's EPS will be -$1.26 for 2024, with the lowest EPS forecast at -$1.33, and the highest EPS forecast at -$1.19. In 2025, AWH's EPS is forecast to hit -$0.87 (min: -$0.87, max: -$0.87).

What is AWH's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: AWH) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.